Symbiotec Pharmalab Limited (NSE:SYMBIOTEC)
India · Delayed Price · Currency is INR 1,150.70
+20.45 (1.81%)
At close: Sep 10, 2026
Symbiotec Pharmalab Market Cap
Symbiotec Pharmalab has a market cap or net worth of 73.18 billion as of September 10, 2026.
Market Cap
73.18B
Enterprise Value
76.99B
Revenue
8.69B
Ranking
n/a
PE Ratio
59.94
Stock Price
1,150.70
ChartMarket Cap Chart
Since September 1, 2026, Symbiotec Pharmalab's market cap has increased from 70.53B to 73.18B, an increase of 3.76%. That is a compound annual growth rate of 346.42%.
| Date | Market Cap | % Change |
|---|---|---|
| Sep 10, 2026 | 73.18B | 0.46% |
| Sep 9, 2026 | 72.85B | 3.62% |
| Sep 8, 2026 | 70.30B | -0.42% |
| Sep 7, 2026 | 70.60B | 1.90% |
| Sep 4, 2026 | 69.28B | 0.13% |
| Sep 3, 2026 | 69.19B | -1.46% |
| Sep 2, 2026 | 70.22B | -0.45% |
| Sep 1, 2026 | 70.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Neuland Laboratories | 298.30B |
| Shilpa Medicare | 188.04B |
| Suven Life Sciences | 94.39B |
| IOL Chemicals and Pharmaceuticals | 61.57B |
| Gujarat Themis Biosyn | 56.13B |
| NGL Fine-Chem | 17.09B |
| Bajaj HealthCare | 11.21B |
| Shree Ganesh Remedies | 8.55B |